Nebivolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C22H25F2NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 030Y90569U, chemically known as 2h-1-benzopyran-2-methanol, alpha,alpha-(iminobis(methylene))bis(6-fluoro-3,4-dihydro- but generally known as nebivolol, which bears US NIH Compound Identifier 71301. European Medicines Agency schedules Nebivolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09175MIG. The term NEBIVOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules nebivolol in its Anatomical Therapeutic Chemical (ATC) Classification. NEBIVOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nebivolol under HS 29329985 and SITC 51569. As of Q4 2014, NEBIVOLOL remains the US FDA Preferred Term for this commodity. Nebivolol bears US NLM identifiers UMLS ID C0068475 and NCI Concept Code C66221. SMILES: FC1CC2CCC(OC2CC1)C(O)CNCC(O)C1OC2C(CC1)CC(F)CC2.